NEFA elevation during a hyperglycaemic clamp enhances insulin secretion

Diabetic Medicine

Volumn 15, Issue 4, 1998, Pages 327-333

  Chalkley, S M ^a   Kraegen, E W ^a   Furler, S M ^a   Campbell, L V ^a   Chisholm, D J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Insulin secretion; Non esterified fatty acids; Type 2 DM risk subjects

Indexed keywords

ARGININE; C PEPTIDE; FATTY ACID; GLUCOSE; HEPARIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; ARGININE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEPARIN; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0031982337     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199804)15:4<327::AID-DIA574>3.0.CO;2-U     Document Type: Article

References (43)

1. Linger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-870.
2. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258:766-770.
3. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E,et al. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 1982; 31: 1128-1136.
4. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737-1747.
5. Felley CP, Felley EM, van Meile CD, Frascarolo P, Jequier E, Felber JP. Impairment of glucose disposal by infusion of triglycérides in humans: role of glycemia. Am J Physiol 1989; 256: E747-E752.
6. Balasse EO, Ooms HA. Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia 1973; 9: 145-151.
7. Carroll KF, Nestel PJ. Effect of long-chain triglyceride on human insulin secretion. Diabetes 1972; 21: 923-929.
8. Collier GR, Greenberg GR, Wolever TM, Jenkins DJ. The acute effect of fat on insulin secretion. J Clin Endocrinol Metab 1988; 66: 323-326.
9. Felber JP, Vannotti A. Effects of fat infusion on glucose tolerance and insulin plasma levels. Med Exp 1964; 10: 153-156.
10. Hicks BH, Taylor CI, Vij SK, Pek S, Knopf RF, Floyd J Jr, Fajans SS. Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man. Metabolism 1977; 26: 1011-1023.
11. Pelkonen R, Miettinen TA, Taskinen MR, Nikkua EA. Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 1968; 17: 76-82.
12. Schalen DS, Kipnis DM. Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 1965; 44: 2010-2020.
13. Young JD, Lazarus L, Chisholm DJ. Radioimmunoassay of pancreozymin cholecystokinin in human serum. J Nucl Med 1969; 10: 743-745.
14. Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 1991; 40: 686-692.
15. Paolisso C, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995; 38: 1295-1299.
16. Boden G, Chen X, Rosner J, Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995; 44: 1239-1242.
17. Porte D Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-180.
18. Chen YD, Golay A, Swislocki AL, Reaven CM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 17-21.
19. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven CM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807-811.
20. Mosteller RD. Simplified calculation of body-surface area (Letter). N Engl J Med 1987; 317: 1098.
21. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA. Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 1989; 257: E49-E56.
22. Lee KU, Lee HK, Koh CS, Min HK. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 1988; 31: 285-290.
23. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody systems. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 1963; 12: 115-126.
24. Kuzuya T, Matsuda A, Saito T, Yoshida S. Human C-peptide immunoreactivity (CPR) in blood and urine: evaluation of a radioimmunoassay method and its clinical applications. Diabetologia 1976; 12: S11-S18.
25. Hennes MM, Dua A, Kissebah AH. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 1997; 46: 57-62.
26. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 1981 ; 53:618-621.
27. Campillo JE, Valdivia MM, Rodriguez E, Osorio C. Effect of oleic and octanoic acids on glucose-induced insulin release in vitro. Diabete Metab 1979; 5: 183-187.
28. Campillo JE, Luyckx AS, Torres MD, Lefebvre PJ. Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia 1979; 16; 267-273.
29. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-1589.
30. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, -Daniels MB, Chen S, McGarry J. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. ; Clin Invest 1996; 97: 2728-2735.
31. Stein DT, Stevenson BE, Chester MW, Basil M, Daniels MB, Turle SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. ) Clin Invest 1997; 100; 398-403.
32. McCance R, Widdovvson E. The Composition of Foods. Cambridge, UK: Xerox Ventura Publisher, 1991: 119.
33. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-876.
34. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 1992; 267: 5802-5810.
35. Prentki M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996; 45: 273-283.
36. Chen S, Ogawa A, Ohneda M, Unger RH, Foster DW, McGarry JD. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes 1994; 43: 878-883.
37. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
38. Schalin-Jantti C, Harkonen M, Groop LC. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992; 41: 598-604.
39. Gelding SV, Coldham N, Niththyananthan R, Anyaoku V, Johnston DG. Insulin resistance with respect to lipolysis in non-diabetic relatives of Europan patients with Type 2 diabetes. Diabetic Med 1995; 12: 66-73.
40. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995; 38: 1213-1217.
41. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW,etal. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672.
42. Meng HC, Edgren B. Source of plasma free fatty acids in dogs receiving fat emulsion and heparin. Am J Physlol 1963; 240: 691-695.
43. Biden TJ, Taylor KW. Effects of ketone bodies on insulin release and islet-cell metabolism in the rat. Biochem J 1983; 212: 371-377.